NCAPG2 and metastatic malignant neoplasm in the lymph nodes: NCAPG2 level were found to be increased in non-small cell lung cancer, and its over-expression was found to be correlated with lymph node metastasis, thus enabling the use of NCAPG2 as a poor prognostic biomarker in lung adenocarcinoma [61].